Bioreactor Designed for Regulated Environments - - BioPharm International

ADVERTISEMENT

Bioreactor Designed for Regulated Environments


GE ReadyToProcess WAVE25 bioreactor

The single-use ReadyToProcess WAVE 25 bioreactor system from GE Healthcare Life Sciences is a cell culture device for designed  for working volumes in the 0.3 to 25 L range. The system consists of a rocker (ReadyToProcess WAVE 25), a gas mixer (ReadyToProcess CBCU), and a pump (ReadyToProcess Pump 25) operated by UNICORN software installed on a client computer.

The system is equipped with advanced sensors and automated controllers for temperature, liquid handling, pH, and dissolved oxygen (DO). The system can automatically determine suitable parameters for a run based on user-defined set points. Cellbag bioreactor attachment is straightforward and system operation is managed using UNICORN software.

The system is designed to meet the demands of a regulated environment. The software is suitable for use in a manner that complies with 21 CFR Part 11 and Good Automated Manufacturing Practice (GAMP) 5.

GE Healthcare Life Sciences

 

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines

Click here